Glucarpidase | Interleukin Related interleukin-related.com

Product Name :
Glucarpidase

Search keywords :
(±)-Methotrexate

drugId :
null

Target Vo:
Methotrexate

Target Vo Short Name :
Methotrexate

Moa_Name:
Methotrexate metabolizers

First Approval Country :
United States

First Approval Date Filter:
2012

Origin Company_Name :
Health Protection Agency Porton Down

Active Company_Name :
Btg International Inc

Active Indication_Name:
Metabolic Side Effects of Drugs and Substances

In Active Indication_Name:
Leukemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sintilimab Biological Activity
CASP4 Antibody MedChemExpress
NQO1 Antibody (YA261): NQO1 Antibody (YA261) is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to NQO1. It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts